The new shares in Medicortex International AB (publ) (formerly NOSIUM AB (publ)) are now registered – the reverse takeover (RTO) of Medicortex Finland is completed, and all conditions in NGM’s conditional approval are hereby met. Adrian Harel takes over as CEO. See the Medicortex International’s press release here.
An information memorandum regarding Medicortex International and its operations is attached here and can also be found in Investors ’Reports and presentations’ section on the website.